Richard Francis
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $1,700,000 | $19,168,709 |
| 2024 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $1,600,000 | $15,518,947 |
| 2023 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $1,600,000 | $25,706,880 |
Executive changes
Earnings-call appearances
-
Q2 2026 Teva Pharmaceutical Industries Ltd. Earnings Conference Call2026-07-29
Teva Pharmaceutical Industries Ltd (TEVA)
-
Goldman Sachs Global Healthcare Conference2026-06-08
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q1 FY2026 Earnings Call2026-04-29
Teva Pharmaceutical Industries Ltd (TEVA)
-
Barclays 28th Annual Global Healthcare Conference2026-03-10
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q4 FY2025 Earnings Call2026-01-28
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q3 FY2025 Earnings Call2025-11-05
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q2 FY2025 Earnings Call2025-07-30
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q1 FY2025 Earnings Call2025-05-07
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q4 FY2024 Earnings Call2025-01-29
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q3 FY2024 Earnings Call2024-11-06
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q2 FY2024 Earnings Call2024-07-31
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q1 FY2024 Earnings Call2024-05-08
Teva Pharmaceutical Industries Ltd (TEVA)
-
Teva Pharmaceutical Industries Ltd Q4 FY2023 Earnings Call2024-01-31
Teva Pharmaceutical Industries Ltd (TEVA)